These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25432854)

  • 21. Transitioning young adults with neurogenic bladder-Are providers asking too much?
    Roth JD; Szymanski KM; Ferguson EJ; Cain MP; Misseri R
    J Pediatr Urol; 2019 Aug; 15(4):384.e1-384.e6. PubMed ID: 31109884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood.
    Snow-Lisy DC; Yerkes EB; Cheng EY
    J Urol; 2015 Aug; 194(2):288-96. PubMed ID: 25839383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current opinions regarding care of the mature pediatric urology patient.
    Szymanski KM; Misseri R; Whittam B; Large T; Cain MP
    J Pediatr Urol; 2015 Oct; 11(5):251.e1-4. PubMed ID: 26148437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demographics and baseline care among newly transitioning adult congenital urology patients.
    Leva NV; Copp HL; Quanstrom K; Hampson LA
    J Pediatr Urol; 2020 Aug; 16(4):476.e1-476.e6. PubMed ID: 32593616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the introduction of an adolescent transition urology clinic using a validated questionnaire.
    Shalaby MS; Gibson A; Granitsiotis P; Conn G; Cascio S
    J Pediatr Urol; 2015 Apr; 11(2):89.e1-5. PubMed ID: 25797859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin injection in the pediatric population with medically refractory neuropathic bladder.
    Khan MK; VanderBrink BA; DeFoor WR; Minevich E; Jackson E; Noh P; Reddy PP
    J Pediatr Urol; 2016 Apr; 12(2):104.e1-6. PubMed ID: 26778185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of adolescents with neurogenic urinary tract and bowel dysfunction.
    de Kort LM; Bower WF; Swithinbank LV; Marschall-Kehrel D; de Jong TP; Bauer SB
    Neurourol Urodyn; 2012 Sep; 31(7):1170-4. PubMed ID: 22460386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A framework for transitioning patients from pediatric to adult health settings for patients with neurogenic bladder.
    Lewis J; Frimberger D; Haddad E; Slobodov G
    Neurourol Urodyn; 2017 Apr; 36(4):973-978. PubMed ID: 27276694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of pediatric neurogenic bladder.
    MacLellan DL
    Curr Opin Urol; 2009 Jul; 19(4):407-11. PubMed ID: 19440150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term study.
    Schulte-Baukloh H; Mürtz G; Heine G; Austin P; Miller K; Michael T; Strugala G; Knispel HH
    J Pediatr Urol; 2012 Aug; 8(4):386-92. PubMed ID: 21907623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How successful is the transition to adult urology care in spina bifida? A single center 7-year experience.
    Szymanski KM; Cain MP; Hardacker TJ; Misseri R
    J Pediatr Urol; 2017 Feb; 13(1):40.e1-40.e6. PubMed ID: 27979598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leading contributors to success of transitional urology units.
    Wood D
    Curr Opin Urol; 2017 Jan; 27(1):7-10. PubMed ID: 27749363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of a minimally invasive surgical approach to manage persistent high-grade vesicoureteric reflux post successful augmentation cystoplasty of patients with non-compliant bladder.
    Alsowayan O; Barham A; Alqarni N; Alnazari M; Alsakharni M; Ewida T; Trbay M; Elderwy AA; Alhazmi H; Neel KF
    J Pediatr Urol; 2015 Apr; 11(2):60.e1-4. PubMed ID: 25294281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of the Transitional Urology Patient: the Role of the Adult Reconstructive Urologist.
    Scarberry KA; Gor RA; Kovell RC
    Curr Urol Rep; 2021 Feb; 22(3):15. PubMed ID: 33534013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of sigmoid bladder augmentation for low-compliance neurogenic bladder.
    Zhang P; Yang Y; Wu ZJ; Zhang N; Zhang CH; Zhang XD
    Urology; 2014 Sep; 84(3):697-701. PubMed ID: 25168554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of the management of acquired neurogenic bladder in children using intradetrusor botulinum toxin type A injections: 5-year experience and perspectives.
    Le Nué R; Harper L; De Sèze M; Bouteiller C; Goossens D; Dobremez E
    J Pediatr Urol; 2012 Oct; 8(5):497-503. PubMed ID: 22115699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urodynamic diagnosis and treatment of neurogenic bladder dysfunction].
    López Pereira P; Eire P; Martínez Urrutia MJ; Moreno JA; Jaureguizar E
    Cir Pediatr; 1992 Jul; 5(3):171-4. PubMed ID: 1389975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bladder augmentation using the gastrointestinal tract. Indication, follow up and complications.
    Escudero RM; Patiño GE; Fernández ER; Gil MJ; García EL; Alonso AH; Piniés GO; Sánchez JP; Fernández CH
    Arch Esp Urol; 2011 Dec; 64(10):953-9. PubMed ID: 22228893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex gynaecological and urological problems in adolescents: challenges and transition.
    Creighton SM; Wood D
    Postgrad Med J; 2013 Jan; 89(1047):34-8. PubMed ID: 23043130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal cord injury in children: long-term urodynamic and urological outcomes.
    Generao SE; Dall'era JP; Stone AR; Kurzrock EA
    J Urol; 2004 Sep; 172(3):1092-4, discussion 1094. PubMed ID: 15311046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.